Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Cancer Therapies02:49

Cancer Therapies

7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A curated dataset of 3,477 high-resolution Grapevine (Vitis vinifera) leaf images for automated detection of Black Rot, Esca, and Leaf Blight diseases.

Scientific data·2026
Same author

A multi-agent large language model framework for intelligent vendor evaluation and risk-aware procurement decisions.

Scientific reports·2026
Same author

Bioinformatics analysis of TRPV1 expression and its role in hepatocellular carcinoma prognosis.

Discover oncology·2026
Same author

Hybrid Aquila optimizer-Harris Hawks optimization for CNN hyperparameter tuning in brain tumor classification.

Scientific reports·2026
Same author

Correlation based feature importance analysis for improving machine learning stability predictions in hybrid PV systems.

Scientific reports·2026
Same author

Synergistic combinatorial anticancer potential of Tamoxifen with Naringin and Diosmetin in MCF-7 breast cancer cells and their liposomal delivery.

Scientific reports·2026
Same journal

MT-MRI for detection of renal interstitial fibrosis in renovascular disease.

Scientific reports·2026
Same journal

Detection of underground objects from GPR data using a lightweight YOLO-based approach.

Scientific reports·2026
Same journal

Early systemic inflammatory-metabolic trajectory phenotypes are associated with survival outcomes in metastatic renal cell carcinoma treated with nivolumab.

Scientific reports·2026
Same journal

Water balance components in a dry-seeded rice-wheat system: Untangling the effects of tillage and mulching practices.

Scientific reports·2026
Same journal

Topological approaches to quantum tensor train compression via ZX-calculus and SVD.

Scientific reports·2026
Same journal

determinants of flood impacts and adaptive capacity among market vendors in Walukuba-Masese, Jinja city, Uganda.

Scientific reports·2026
See all related articles

Related Experiment Video

Updated: Jul 29, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K

Unlocking multidimensional cancer therapeutics using geometric data science.

Deepak Parashar1,2,3

  • 1Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK. D.Parashar@warwick.ac.uk.

Scientific Reports
|May 22, 2023
PubMed
Summary
This summary is machine-generated.

Novel geometric methods visualize complex cancer therapeutics and clinical trial designs. This approach aids in targeting multiple therapies for sensitive patient populations across diverse cancer types and biomarkers.

More Related Videos

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
07:47

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Published on: December 15, 2023

756
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.3K

Related Experiment Videos

Last Updated: Jul 29, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K
Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
07:47

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Published on: December 15, 2023

756
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.3K

Area of Science:

  • Oncology
  • Computational Biology
  • Biostatistics

Background:

  • Personalized cancer therapeutics rely on identifying patient subgroups likely to respond to targeted drugs.
  • Stratification for targeted therapies complicates clinical trial designs with biomarkers and tissue types.
  • Existing statistical methods lag behind rapid advancements in cancer research.

Purpose of the Study:

  • To develop novel analytic tools for complex cancer therapeutics and clinical trial designs.
  • To effectively target multiple therapies for sensitive patient populations using biomarker panels across multiple cancer types.
  • To establish a framework for incorporating multi-omics data into multidimensional therapeutics.

Main Methods:

  • Application of novel geometric methods, specifically the mathematical theory of hypersurfaces.
  • Visualization of complex cancer therapeutics data in multidimensional space.
  • Geometric representation of oncology trial design space in higher dimensions.

Main Results:

  • Demonstrated visualization of complex cancer therapeutics data using hypersurfaces.
  • Developed a geometric representation for higher-dimensional oncology trial design space.
  • Applied hypersurfaces to describe master protocols, exemplified by a melanoma basket trial design.

Conclusions:

  • Geometric methods offer a novel framework for analyzing complex cancer therapeutics and trial designs.
  • This approach facilitates the integration of multi-omics data for personalized cancer treatment strategies.
  • The developed framework supports the design of adaptive and efficient clinical trials for targeted therapies.